Human fibroblast interferon in human neoplasia: clinical and laboratory study.
Human fibroblast interferon (HFIF) produced on a large scale from normal diploid cell strains was highly purified and then evaluated as to its safety clinical investigation. The selective antiproliferative activity of HFIF was observed in vitro against certain human malignant cell lines and in vivo against human bladder tumors grown in nude mice. Direct injections of HFIF into metastatic melanoma lesions of two patients resulted in either the disappearance of malignant cells or the significant reduction in tumor volume.
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D004341:Drug Evaluation; D005347:Fibroblasts / Q000276:immunology; D006801:Humans; D007372:Interferons / Q000302:isolation & purification / Q000494:pharmacology* / Q000633:toxicity; D008545:Melanoma / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011786:Quality Control; D051381:Rats; D012867:Skin / Q000187:drug effects; D012878:Skin Neoplasms / Q000188:drug therapy*
D007372:Interferons